Trials / Unknown
UnknownNCT06322277
Use of Low-cost Molecular Diagnostic Techniques as a New Surveillance Model for Diseases Preventable by Vaccinations.
The Regional Pediatric Network and the Use of Low-cost Molecular Diagnostic Techniques Cost as a New Management and Surveillance Model for Diseases Preventable by Vaccinations.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1 (estimated)
- Sponsor
- Meyer Children's Hospital IRCCS · Academic / Other
- Sex
- All
- Age
- 1 Day – 18 Years
- Healthy volunteers
- Not accepted
Summary
Vaccine-preventable disease (VPD) surveillance should be a priority throughout the world. In Italy, however, there is limited attention to the epidemiology of VPDs, with the consequence that their incidence is largely underestimated. Although notification of vaccine-preventable diseases is mandatory, very often the etiologic agents causing VPDs are not identified the etiological agents causing the major and most severe infectious diseases in childhood. Several reasons underlie the underestimation. For example, not having a good surveillance system does not allow us to organize a sustainable prevention project for example based on on the introduction of new vaccinations. For example the limited use of low-cost high-sensitivity techniques such as real-time PCR, which could, if more widely used, improve pathogen identification with 3 times the sensitivity of standard cultural methods. Therefore, the idea of this multicenter, biological sample study is to take advantage of the regional pediatric network with the goal of improving VPD surveillance and increase awareness of the importance of surveillance of preventable diseases with the vaccine within the pediatric network.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Analysis of biological sample | Confermation of type of infection with RT-PCR. |
Timeline
- Start date
- 2021-05-04
- Primary completion
- 2025-02-28
- Completion
- 2025-03-31
- First posted
- 2024-03-21
- Last updated
- 2024-03-21
Locations
4 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT06322277. Inclusion in this directory is not an endorsement.